Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Inventory Average: 2018-2025

Historic Inventory Average for Agios Pharmaceuticals (AGIO) over the last 6 years, with Sep 2025 value amounting to $31.4 million.

  • Agios Pharmaceuticals' Inventory Average rose 24.85% to $31.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.4 million, marking a year-over-year increase of 24.85%. This contributed to the annual value of $23.3 million for FY2024, which is 69.37% up from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Inventory Average of $31.4 million as of Q3 2025, which was up 4.02% from $30.2 million recorded in Q2 2025.
  • In the past 5 years, Agios Pharmaceuticals' Inventory Average ranged from a high of $31.4 million in Q3 2025 and a low of $3.3 million during Q2 2022.
  • Over the past 3 years, Agios Pharmaceuticals' median Inventory Average value was $23.5 million (recorded in 2024), while the average stood at $22.3 million.
  • Data for Agios Pharmaceuticals' Inventory Average shows a peak YoY spiked of 313.22% (in 2023) over the last 5 years.
  • Over the past 4 years, Agios Pharmaceuticals' Inventory Average (Quarterly) stood at $6.8 million in 2022, then surged by 165.95% to $18.2 million in 2023, then skyrocketed by 48.68% to $27.0 million in 2024, then grew by 24.85% to $31.4 million in 2025.
  • Its last three reported values are $31.4 million in Q3 2025, $30.2 million for Q2 2025, and $28.6 million during Q1 2025.